Maravai LifeSciences (MRVI) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MRVI Maravai LifeSciences

Watchlist

4.010
-0.100-2.43%

Close Feb 24 16:00 ET

3.800
-0.210-5.24%

Pre 06:02 ET

568.79MMarket Cap-2.40P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Press Release: Maravai LifeSciences Postpones Its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
Dow Jones12minutes ago
Earnings Scheduled For February 25, 2025
Benzinga03:32 ET
Maravai LifeSciences Holdings Q4 2024 Earnings Preview
Seeking Alpha17:35 ET
Express News | Maravai LifeSciences Completes Acquisition of the DNA and Rna Business of Officinae Bio
ReutersFeb 24 08:00 ET
Press Release: Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
Dow JonesFeb 24 08:00 ET
Maravai LifeSciences Completes Acquisition Of The DNA And RNA Business Of Officinae Bio >MRVI
Dow JonesFeb 24 08:00 ET

Comments

Teddy123

21 hours ago

Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio

$Maravai LifeSciences (MRVI.US)$
AI Meets mRNA: How Maravai's Latest Acquisition Reshapes Drug Development

DrC 504

Jan 21 09:34

A DIAMOND IN THE ROUGH

$Maravai LifeSciences (MRVI.US)$ UNDERVALUED FALLING STAR stock swing trade - healthcare - mid cap - 5/9 F-Score - 0.75x relative volume - 1x analyst outperform rating - 2x analysts outperform rating - 2x analysts buy rating - trading at 42% below estimate of its fair value - short to medium term gains 📈

Stock_Drift

Sep 24, 2024 07:16

$Maravai LifeSciences (MRVI.US)$

Moomoo AI

Apr 6, 2024 09:07

Despite Maravai LifeSciences Holdings' significant liabilities, it has net cash, indicating a light debt load. However, its pre-interest and tax loss and declining revenue raise future earnings and balance sheet health concerns.

Is Maravai LifeSciences Holdings (NASDAQ:MRVI) Using Debt In A Risky Way?

Moomoo AI

Dec 21, 2023 06:11

While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

MRVI Maravai LifeSciences

Trade Overview

Capital Trend

News

Comments

Trending Stocks